Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a man or woman aged 65 or older who either cannot receive a stem cell transplant or does not plan to have one right away
- You have been diagnosed with multiple myeloma, confirmed by a bone marrow test showing at least 10% abnormal plasma cells, or a biopsy confirming a related tumor (plasmacytoma)
- Your multiple myeloma can be measured through blood or urine tests showing certain protein levels above specific thresholds (confirm with trial site for exact values)
- You have never received any treatment specifically targeting your multiple myeloma before
- Your heart, liver, kidneys, and other organs are healthy enough to handle treatment
- You (or your legal representative) are willing to sign a consent form and follow all the rules of the study
Who may not be able to join:
- You currently have an active infection (such as a viral, fungal, or bacterial infection) that requires medication to treat it
- You have serious heart or liver problems — for example, severe heart failure or significantly elevated liver enzymes — unless these are caused by multiple myeloma itself
- You have had a previous blood cancer or solid tumor that was treated with radiation or chemotherapy within the last 5 years
- You currently have another blood cancer or solid tumor that requires radiation or chemotherapy treatment
- You are unwilling or unable to sign the informed consent form
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall response rate (at least PR) on induction therapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.